Unknown

Dataset Information

Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapy.


ABSTRACT:

Background

Peritoneal metastasis from colorectal cancer (CRC) carries a poor prognosis in most studies. The majority of those studies used either a single-agent or doublet chemotherapy regimen in the first-line setting.

Aim

To investigate the prognostic significance of peritoneal metastasis in a cohort of patients treated with triplet chemotherapy in the first-line setting.

Methods

We retrospectively evaluated progression-free survival (PFS) and overall survival (OS) in 51 patients with metastatic CRC treated in a prospective clinical trial with capecitabine, oxaliplatin, irinotecan, and bevacizumab in the first-line setting according to the presence and absence of peritoneal metastasis. Furthermore, univariate and multivariate analyses for PFS and OS were performed t

SUBMITTER: Bazarbashi S 

PROVIDER: S-EPMC8968618 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature